Retaglutide is a novel GLP-1 receptor agonist currently under study for the control of metabolic disorders. This medication works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://nicolasnmcs000175.ourcodeblog.com/39350418/retaglutide-a-promising-glp-1-receptor-agonist